Paul Tudor Jones's EVH Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 102,867 shares of Evolent Health, Inc. (EVH) worth $234,537, representing 0.00% of the portfolio. First purchased in 2015-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in EVH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 438,095 shares. Largest reduction occurred in Q1 2026, reducing 599,254 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Evolent Health (EVH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Evolent Health (EVH) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -599,254 | Reduce 85.35% | 102,867 | $2.28 |
| Q4 2025 | +12,859 | Add 1.87% | 702,121 | $4.00 |
| Q3 2025 | +438,095 | Add 174.42% | 689,262 | $8.46 |
| Q2 2025 | -400,819 | Reduce 61.48% | 251,167 | $11.26 |
| Q1 2025 | +325,726 | Add 99.84% | 651,986 | $9.47 |
| Q4 2024 | +160,769 | Add 97.15% | 326,260 | $11.25 |
| Q3 2024 | -249,713 | Reduce 60.14% | 165,491 | $28.28 |
| Q2 2024 | -6,215 | Reduce 1.47% | 415,204 | $19.12 |
| Q1 2024 | +312,106 | Add 285.52% | 421,419 | $32.79 |
| Q4 2023 | +109,313 | New Buy | 109,313 | $33.03 |
| Q2 2023 | -109,715 | Sold Out | 0 | $0.00 |
| Q1 2023 | +109,715 | New Buy | 109,715 | $0.03 |
| Q4 2022 | -41,235 | Sold Out | 0 | $0.00 |
| Q3 2022 | +41,235 | New Buy | 41,235 | $35.94 |
| Q4 2021 | -125,000 | Sold Out | 0 | $0.00 |
| Q3 2021 | +125,000 | New Buy | 125,000 | $31.00 |
| Q2 2021 | -16,869 | Sold Out | 0 | $0.00 |
| Q1 2021 | -45,817 | Reduce 73.09% | 16,869 | $20.21 |
| Q4 2020 | +62,686 | New Buy | 62,686 | $16.03 |
| Q1 2016 | -15,200 | Sold Out | 0 | $0.00 |
| Q3 2015 | -32,019 | Reduce 67.81% | 15,200 | $15.99 |
| Q2 2015 | +47,219 | New Buy | 47,219 | $19.50 |
Paul Tudor Jones's Evolent Health Investment FAQs
Paul Tudor Jones first purchased Evolent Health, Inc. (EVH) in Q2 2015, acquiring 47,219 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Evolent Health, Inc. (EVH) for 23 quarters since Q2 2015.
Paul Tudor Jones's largest addition to Evolent Health, Inc. (EVH) was in Q3 2025, adding 689,262 shares worth $5.83 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 102,867 shares of Evolent Health, Inc. (EVH), valued at approximately $234,537.
As of the Q1 2026 filing, Evolent Health, Inc. (EVH) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Evolent Health, Inc. (EVH) was 702,121 shares, as reported at the end of Q4 2025.